All lobbying filings

2359 STRATEGIES

Lobbying for TRAVERE THERAPEUTICS · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $12,000.00 income · posted Apr 19, 2025

Official filing document

Bills named in this filing 1

HR 1518
New Era of Preventing End-Stage Kidney Disease Act

Lobbying activity 5

Medicare/Medicaid

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Health Issues

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Medical/Disease Research/Clinical Labs

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Pharmacy

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Taxation/Internal Revenue Code

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem